| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 10 4613-4620, Copyright © 1995 by American Association of Immunologists
ARTICLES |
B Kruszewska, SY Felten and JA Moynihan
Center for Psychoneuroimmunology Research, University of Rochester Medical Center, NY 14642, USA.
It is becoming clear that immune responses are subject to modulation by the sympathetic nervous system. We examined the effect of chemical sympathectomy (to ablate peripheral sympathetic nerve fibers) on cytokine and Ab production in two strains of mice that are known to differ in their response to a variety of pathogens and in the dominant types of cytokines produced. C57Bl/6J mice produce a strong cell- mediated response, characterized by production of IL-2 and IFN-gamma, whereas BALB/cJ have a dominant humoral response, with production of IL- 4 and IL-10. Animals were denervated by injection with 6- hydroxydopamine and immunized with keyhole limpet hemocyanin, and spleens were removed at various times after immunization. Denervation significantly increased the keyhole-limpet-hemocyanin-stimulated in vitro proliferation and IL-2 and IL-4 production by splenocytes from both strains. The increases were prevented by pretreatment with desipramine, which blocks the uptake of 6-hydroxydopamine into the nerve fibers and subsequent nerve fiber destruction. Serum titers of IgM, IgG, IgG1, and IgG2a were also enhanced in the C57Bl/6J strain; BALB/cJ mice had a small increase in IgG1 only. These results suggest that one function of splenic innervation and transmitter release may be to modulate T helper cytokines, thereby partially regulating immune effector function. Our evidence is consistent with a model of immune regulation in which removal of sympathetic nervous system input enhances at least some parameters of immune responses.
This article has been cited by other articles:
|
|
 |
|
  K. S. Rommelfanger, G. L. Edwards, K. G. Freeman, L. C. Liles, G. W. Miller, and D. Weinshenker Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice PNAS, August 21, 2007; 104(34): 13804 - 13809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.R. Haug and K.J. Heyeraas Modulation of Dental Inflammation by the Sympathetic Nervous System Journal of Dental Research, June 1, 2006; 85(6): 488 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. Kin and V. M. Sanders It takes nerve to tell T and B cells what to do J. Leukoc. Biol., June 1, 2006; 79(6): 1093 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. del Rey, E. Roggero, A. Kabiersch, M. Schafer, and H. O. Besedovsky The Role of Noradrenergic Nerves in the Development of the Lymphoproliferative Disease in Fas-Deficient, lpr/lpr Mice. J. Immunol., June 1, 2006; 176(11): 7079 - 7086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Chida, N Sudo, A Takaki, and C Kubo The hepatic sympathetic nerve plays a critical role in preventing Fas induced liver injury in mice Gut, July 1, 2005; 54(7): 994 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Pruett, R. Fan, Q. Zheng, L. P. Myers, and P. Hebert Modeling and Predicting Immunological Effects of Chemical Stressors: Characterization of a Quantitative Biomarker for Immunological Changes Caused by Atrazine and Ethanol Toxicol. Sci., October 1, 2003; 75(2): 343 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Kohm, A. Mozaffarian, and V. M. Sanders B Cell Receptor- and {beta}2-Adrenergic Receptor-Induced Regulation of B7-2 (CD86) Expression in B Cells J. Immunol., June 15, 2002; 168(12): 6314 - 6322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miura, T. Kudo, A. Matsuki, K. Sekikawa, Y.-I. Tagawa, Y. Iwakura, and A. Nakane Effect of 6-Hydroxydopamine on Host Resistance against Listeria monocytogenes Infection Infect. Immun., December 1, 2001; 69(12): 7234 - 7241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Kohm and V. M. Sanders Norepinephrine and beta 2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function in Vitro and in Vivo Pharmacol. Rev., December 1, 2001; 53(4): 487 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Pruett, R. Fan, Q. Zheng, L. P. Myers, and P. Hebert Modeling and Predicting Selected Immunological Effects of a Chemical Stressor (3,4-Dichloropropionanilide) Using the Area under the Corticosterone Concentration versus Time Curve Toxicol. Sci., November 1, 2000; 58(1): 77 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Exton, A. Elfers, W.-Y. Jeong, D. F. Bull, J. Westermann, and M. Schedlowski Conditioned suppression of contact sensitivity is independent of sympathetic splenic innervation Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1310 - R1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Marriott and K. L. Bost IL-4 and IFN-{gamma} Up-Regulate Substance P Receptor Expression in Murine Peritoneal Macrophages J. Immunol., July 1, 2000; 165(1): 182 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sacerdote, B. Manfredi, L. Gaspani, and A. E. Panerai The opioid antagonist naloxone induces a shift from Type 2 to Type 1 cytokine pattern in BALB/cJ mice Blood, March 15, 2000; 95(6): 2031 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Exton, M. Schult, S. Donath, T. Strubel, U. Bode, A. del Rey, J. Westermann, and M. Schedlowski Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1710 - R1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Kohm and V. M. Sanders Suppression of Antigen-Specific Th2 Cell-Dependent IgM and IgG1 Production Following Norepinephrine Depletion In Vivo J. Immunol., May 1, 1999; 162(9): 5299 - 5308. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
